Autor: "Emery, Robert C." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Preclinical Ultra-High Dose Rate (FLASH) Proton Radiation Therapy System for Small Animal Studies
Autorzy:: Cao, Ning
Erickson, Danielle P. Johnson
Ford, Eric C.
Emery, Robert C.
Kranz, Marissa
Goff, Peter
Schwarz, Marco
Meyer, Juergen
Wong, Tony
Saini, Jatinder
Bloch, Charles
Stewart, Robert D.
Sandison, George A.
Morimoto, Alec
DeLonais-Dick, Ava
Shaver, Ben A.
Rengan, Ramesh
Zeng, Jing; Pokaż więcej
Źródło:: In Advances in Radiation Oncology March 2024 9(3)

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Deuteron irradiation of W and WO3 for production of high specific activity 186Re: Challenges associated with thick target preparation
Autorzy:: Balkin, Ethan R.
Gagnon, Katherine
Strong, Kevin T.
Smith, Bennett E.
Dorman, Eric F.
Emery, Robert C.
Pauzauskie, Peter J.
Fassbender, Michael E.
Cutler, Cathy S.
Ketring, Alan R.
Jurisson, Silvia S.
Wilbur, D. Scott; Pokaż więcej
Źródło:: In Applied Radiation and Isotopes September 2016 115:197-207

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3.

Tytuł:: 57 - A Phase I Trial of First-in-Human Alpha-Emitter Astatine-211-Labeled Anti-CD45 Antibody (211At-BC8-B10) in Combination with Fludarabine and TBI As Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS): Preliminary Results of Dose Escalation
Autorzy:: Sandmaier, Brenda M.
Wilbur, D. Scott
Hamlin, Donald K.
Vo, Phuong
Wong, Roger
Baker, Kelsey
Haaf, Robyn
Bouvier, Michelle E.
Matesan, Manuela C.
Li, Yawen
Orozco, Johnnie J.
Nartea, Margaret
Santos, Erlinda B.
Dorman, Eric
Vesselle, Hubert
Lewis, David H.
Behnia, Sanaz
Green, Damian J.
Emery, Robert C.
Rajendran, Joseph G.
Gooley, Ted A.
Storb, Rainer; Pokaż więcej
Źródło:: In Transplantation and Cellular Therapy March 2021 27(3) Supplement:S54-S54

Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4.

Czasopismo naukowe

Skocz do pozycji: 5.

Tytuł:: A Phase I Trial of First-in-Human Alpha-Emitter Astatine-211-Labeled Anti-CD45 Antibody (211At-BC8-B10) in Combination with Fludarabine and TBI As Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS): Preliminary Results of Dose Escalation
Autorzy:: Sandmaier, Brenda M.
Wilbur, D. Scott
Hamlin, Donald K.
Vo, Phuong
Wong, Roger
Baker, Kelsey
Haaf, Robyn
Bouvier, Michelle E.
Matesan, Manuela C.
Li, Yawen
Orozco, Johnnie J.
Nartea, Margaret
Santos, Erlinda B.
Dorman, Eric
Vesselle, Hubert
Lewis, David H.
Behnia, Sanaz
Green, Damian J.
Emery, Robert C.
Rajendran, Joseph G.
Gooley, Ted A.
Storb, Rainer; Pokaż więcej
Źródło:: Transplantation and Cellular Therapy; March 2021, Vol. 27 Issue: 3, Number 3 Supplement 1 pS54-S54, 1p

Periodyk

Szczegóły

Informacja